Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery
- PMID: 7689744
- DOI: 10.3109/00365529309096091
Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery
Abstract
The incidence of post-transfusion hepatitis non-A, non-B (PTH-NANB) was prospectively assessed among open-heart surgery patients from the southeast region of Sweden before the introduction of antihepatitis C virus (HCV) blood donor screening. Blood samples for alanine aminotransferase analysis were drawn before and 2, 3, and 4 months after transfusion. Surgery was performed in four centres. Of 190 transfused and followed-up patients 2 (1.1%) contracted PTH-NANB, both operated on at the centre with significantly fewer transfusions than the other centres. One patient had antibodies to HCV detected by first-generation (C100-3) and later by second-generation anti-HCV enzyme-linked immunosorbent assay (ELISA-2) and by positive second-generation recombinant immunoblot assay (4-RIBA). The other patient, although negative by first-generation anti-HCV ELISA, was positive by second-generation ELISA and by 4-RIBA. Both patients were hepatitis C-viremic by polymerase chain reaction (PCR). All the six donors implicated in the two hepatitis cases were first-generation anti-HCV-negative, but two, one for each patient, were positive by second-generation anti-HCV ELISA. This finding was confirmed by positive 4-RIBA in only 1 donor, the other being 'indeterminate'. However, in both donors hepatitis C viremia was found by PCR. This study shows that the second-generation anti-HCV ELISA will further reduce the risk for PTH-NANB/C and draws attention to the problem of evaluation of confirmatory tests.
Similar articles
-
Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.Scand J Gastroenterol. 1992 Jun;27(6):443-8. doi: 10.3109/00365529209000103. Scand J Gastroenterol. 1992. PMID: 1321487
-
Early antihepatitis C virus response with second-generation C200/C22 ELISA.Vox Sang. 1992;62(4):208-12. doi: 10.1111/j.1423-0410.1992.tb01200.x. Vox Sang. 1992. PMID: 1322611
-
Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors.Dig Dis Sci. 1996 Oct;41(10):1933-8. doi: 10.1007/BF02093592. Dig Dis Sci. 1996. PMID: 8888703
-
Hepatitis C virus infection from blood and blood products.FEMS Microbiol Rev. 1994 Jul;14(3):241-6. doi: 10.1111/j.1574-6976.1994.tb00094.x. FEMS Microbiol Rev. 1994. PMID: 7522022 Review.
-
Non-A, non-B hepatitis and the anti-HCV assay.Vox Sang. 1991;60(1):1-7. doi: 10.1111/j.1423-0410.1991.tb00863.x. Vox Sang. 1991. PMID: 1711260 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical